First Time Loading...

EyePoint Pharmaceuticals Inc
NASDAQ:EYPT

Watchlist Manager
EyePoint Pharmaceuticals Inc Logo
EyePoint Pharmaceuticals Inc
NASDAQ:EYPT
Watchlist
Price: 12.45 USD 1.88%
Updated: May 15, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

355.2m
+122%
Assets
Growth Rates:
1 Year
+97%
3 Years
+287%
5 Years
+354%
7 Years
+1 703%
10 Years
+1 608%
88.9m
-12%
Liabilities
Growth Rates:
1 Year
+6%
3 Years
+21%
5 Years
+119%
7 Years
+1 677%
10 Years
+984%
266.3m
+354%
Equity
Growth Rates:
1 Year
+176%
3 Years
+1 340%
5 Years
+608%
7 Years
+1 699%
10 Years
+2 014%

Balance Sheet Decomposition
EyePoint Pharmaceuticals Inc

355.2m
Assets
88.9m
Liabilities
355.2m
Assets
88.9m
Liabilities
Current Assets 344.8m
Cash & Short-Term Investments 331.1m
Receivables 805k
Other Current Assets 12.9m
Non-Current Assets 10.4m
PP&E 10.2m
Other Non-Current Assets 150k
Current Liabilities 63.3m
Accounts Payable 30.5m
Accrued Liabilities 17.5m
Other Current Liabilities 15.2m
Non-Current Liabilities 25.6m
Other Non-Current Liabilities 25.6m

Balance Sheet
EyePoint Pharmaceuticals Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
45
22
45
179
96
281
Cash Equivalents
45
22
45
179
96
281
Short-Term Investments
0
0
0
33
49
50
Total Receivables
1
11
10
18
16
1
Accounts Receivables
1
11
10
18
16
1
Other Receivables
0
0
0
0
0
0
Inventory
0
2
5
4
3
4
Other Current Assets
1
6
3
4
10
9
Total Current Assets
48
42
63
238
173
345
PP&E Net
0
3
3
3
7
10
PP&E Gross
0
3
3
3
7
10
Accumulated Depreciation
1
1
1
1
2
3
Intangible Assets
30
28
25
23
0
0
Other Long-Term Assets
0
0
0
0
0
0
Total Assets
78
N/A
73
-7%
92
+26%
263
+187%
180
-32%
355
+97%
Liabilities
Accounts Payable
3
4
5
7
6
31
Accrued Liabilities
19
7
9
15
17
18
Short-Term Debt
0
0
0
0
11
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
Other Current Liabilities
0
0
1
1
1
39
Total Current Liabilities
22
12
15
24
35
63
Long-Term Debt
18
47
38
37
29
0
Other Liabilities
2
6
20
19
20
26
Total Liabilities
41
N/A
65
+60%
73
+13%
79
+8%
84
+6%
89
+6%
Equity
Common Stock
0
0
0
0
0
0
Retained Earnings
409
465
511
569
671
742
Additional Paid In Capital
445
473
528
753
767
1 008
Other Equity
1
1
1
1
1
1
Total Equity
38
N/A
8
-78%
19
+123%
184
+897%
96
-48%
266
+176%
Total Liabilities & Equity
78
N/A
73
-7%
92
+26%
263
+187%
180
-32%
355
+97%
Shares Outstanding
Common Shares Outstanding
10
11
18
34
34
49

See Also

Summary
EYPT intrinsic value, competitors valuation, and company profile.
DCF Valuation
EYPT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EYPT stock valuation using valuation multiples.
Wall Street Estimates
EYPT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EYPT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.